Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind phase IIb trial of Fufang Yizhihao Keli in pediatric acute upper respiratory infection (Naizilai type)
CTR20251593Phase 2Active
- Sponsor
- Yindolan Pharmaceutical
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fufang Yizhihao in upper respiratory infection (URI), sponsored by Yindolan Pharmaceutical. Started Apr 2025; status: active.
02
Drugs
Fufang Yizhihao
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20251593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251593.